Design Therapeutics, Inc.
DSGN
$9.77
$0.839.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 205.97M | 216.28M | 229.67M | 245.48M | 254.07M |
| Total Receivables | 1.38M | 1.35M | 1.41M | 1.26M | 1.18M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.68M | 2.17M | 2.57M | 1.30M | 1.99M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 209.03M | 219.79M | 233.64M | 248.04M | 257.24M |
|
|
|||||
| Total Current Assets | 209.03M | 219.79M | 233.64M | 248.04M | 257.24M |
| Net Property, Plant & Equipment | 2.74M | 3.09M | 3.40M | 3.63M | 3.96M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 427.00K | 427.00K | 427.00K |
| Total Assets | 211.77M | 222.89M | 237.48M | 252.09M | 261.63M |
|
|
|||||
| Total Accounts Payable | 1.91M | 1.01M | 3.18M | 2.19M | 1.47M |
| Total Accrued Expenses | 8.39M | 6.89M | 4.24M | 5.48M | 5.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 866.00K | 844.00K | 821.00K | 800.00K | 778.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.17M | 8.75M | 8.24M | 8.46M | 7.43M |
|
|
|||||
| Total Current Liabilities | 11.17M | 8.75M | 8.24M | 8.46M | 7.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 877.00K | 1.10M | 1.32M | 1.53M | 1.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.05M | 9.85M | 9.56M | 10.00M | 9.18M |
|
|
|||||
| Common Stock & APIC | 480.37M | 476.74M | 472.40M | 468.84M | 465.10M |
| Retained Earnings | -281.01M | -264.01M | -244.93M | -227.21M | -213.56M |
| Treasury Stock & Other | 358.00K | 305.00K | 450.00K | 475.00K | 914.00K |
| Total Common Equity | 199.72M | 213.04M | 227.92M | 242.10M | 252.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 199.72M | 213.04M | 227.92M | 242.10M | 252.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 199.72M | 213.04M | 227.92M | 242.10M | 252.45M |
|
|
|||||